drugset / Trial / NCT04737343

Summary

This study is a prospective, open-labelled, randomized, controlled,multi-center clincial trial. The aim of this study is to verify that the remission rate of patients treated with Leflunomide is not inferior to that of patients treated with Azathioprine.

Timeline

Start
2021-06-30
Primary completion
2024-11-30
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azathioprine Small molecule 100 mg
Subject Leflunomide Small molecule 30 mg